PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
ID: 355903Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$900K - $1M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355903
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) has announced a funding opportunity titled "PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention." This initiative aims to support an implementation research study that evaluates strategies for integrating Postexposure Prophylaxis (PEP) packs into existing Pre-exposure Prophylaxis (PrEP) services, specifically targeting populations disproportionately affected by HIV, such as Black and Hispanic men who have sex with men (MSM) and transgender women (TGW). The program seeks to enhance access to nonoccupational PEP (nPEP) and includes the provision of starter kits containing nPEP medications, STI prophylaxis treatment, and self-testing kits to facilitate immediate prevention following potential exposures. The total funding available for this opportunity is $4.8 million, with a single award anticipated, and applications must be submitted electronically by February 19, 2025. For further inquiries, interested parties can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.

    Point(s) of Contact
    JPatterson@cdc.gov
    Files
    Title
    Posted
    RFA-PS-25-112_20241213.pdf
    The CDC's National Center for HIV, Viral Hepatitis, STD, and TB Prevention has issued a Notice of Funding Opportunity (RFA-PS-25-112) to implement and evaluate a strategy for integrating Postexposure Prophylaxis (Pep) Packs into existing Pre-exposure Prophylaxis (PrEP) services. This initiative aims to enhance access to nonoccupational postexposure prophylaxis (nPEP) for populations disproportionately affected by HIV, specifically Black and Hispanic men who have sex with men (MSM) and transgender women (TGW). The PiP approach consists of providing starter kits containing nPEP medications, STI prophylaxis treatment, and self-testing kits, fostering immediate prevention following potential exposures. The funding opportunity anticipates one award, totaling $4.8 million across four years, to support research activities focusing on timely nPEP initiation, user acceptance of PEP packs, and clinical service quality. Eligible organizations include state and local governments, non-profits, and public educational institutions. Applications must be submitted electronically by February 19, 2025. By improving access and reducing systemic barriers to prompt care, this initiative aligns with national public health goals to decrease HIV infections and improve health outcomes for marginalized populations.
    Similar Opportunities
    Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances." This initiative aims to support pilot research focused on developing and testing behavioral implementation strategies for biomedical interventions, such as oral PrEP and condom use, to enhance HIV and STI prevention among disproportionately affected populations, particularly Black and Hispanic men who have sex with men (MSM) who report substance use. The funding, totaling $2.85 million, is intended for a three-year performance period, with two awards expected, each ranging from $350,000 to $475,000. Interested applicants must submit their proposals by February 20, 2025, with the project anticipated to commence on September 1, 2025. For further inquiries, applicants can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.
    Implementation and Evaluation of PrEPmate: An evidence-based short message service/text-based PrEP intervention for YMSM and Transgender women of color
    Active
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity for the implementation and evaluation of PrEPmate, a mobile health intervention aimed at enhancing HIV pre-exposure prophylaxis (PrEP) adherence among young men who have sex with men (YMSM) and transgender women of color. The initiative seeks to facilitate the deployment of PrEPmate at three clinical sites in the southern United States, focusing on improving patient adherence and retention in PrEP care through tailored interactive content, reminders, and a monitoring dashboard. With an estimated total program funding of $3 million and one expected award, interested applicants can reach out to Charles Collins at cwc4@cdc.gov or by phone at 404-639-0966. The application deadline is set for March 7, 2025, with project commencement anticipated on July 1, 2025.
    Combination prevention solutions to reach epidemic control among high risk, priority populations in high burden areas in South Africa (SA) under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at implementing combination prevention solutions to control the HIV epidemic among high-risk populations in South Africa under the President's Emergency Plan for AIDS Relief (PEPFAR). This cooperative agreement seeks to provide targeted interventions, particularly for adolescents aged 10-24, focusing on evidence-based biomedical, behavioral, and structural approaches to reduce new HIV infections and improve health equity. The estimated funding amount for the first year is $25 million, with applications due by February 20, 2025. Interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    Strengthening comprehensive HIV prevention interventions in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity to strengthen comprehensive HIV prevention interventions in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative aims to reduce new HIV infections through a combination of biomedical, behavioral, and structural interventions, specifically targeting high-risk populations in districts with significant HIV burdens. This program is crucial for addressing health equity and achieving epidemic control in HIV services, with an anticipated funding amount of $5 million for the first year and the expectation of awarding 1-2 grants over a five-year period. Interested applicants, including state and local governments, nonprofits, and foreign entities, must submit their applications by February 18, 2025, and can direct inquiries to Emily Dale at pepfarfoas@cdc.gov.
    Supporting the implementation of comprehensive HIV prevention and treatment programs to achieve and sustain epidemic control in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity to support comprehensive HIV prevention and treatment programs in Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative aims to enhance HIV services, including prevention, testing, treatment adherence, and management of co-morbidities, particularly for priority populations such as key populations and adolescents. This funding is crucial for achieving long-term HIV epidemic control goals and strengthening public health infrastructure in Zimbabwe. Interested applicants can submit their proposals by February 18, 2025, with an anticipated funding amount of $10 million for the first year, and should contact Emily Dale at pepfarfoas@cdc.gov for further information.
    Building capacity along the continuum from prevention to care and treatment in the Central American region under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at enhancing the capacity for HIV prevention, diagnosis, and treatment in Central American countries under the President's Emergency Plan for AIDS Relief (PEPFAR). This initiative seeks to address critical gaps in health services across El Salvador, Guatemala, Honduras, Nicaragua, and Panama, with a focus on achieving the 10-10-10 prevention objectives and the 95-95-95 care targets by 2030. Eligible applicants, including government entities, NGOs, and foreign organizations, are encouraged to develop comprehensive strategies for HIV prevention and treatment, while also enhancing the skills of healthcare workers through training and quality improvement initiatives. The application deadline is February 24, 2025, with an estimated total funding of $20 million for the first year and two awards anticipated. For further inquiries, applicants can contact Emily Dale at pepfarfoas@cdc.gov.
    Improving HIV prevention and treatment in the Dominican Republic with a focus on priority populations under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at improving HIV prevention and treatment in the Dominican Republic, particularly for priority populations such as Haitian migrants. The initiative seeks to enhance access to HIV testing and treatment, ensure retention in care, and reduce new infections through community outreach and evidence-based interventions, emphasizing collaboration with local health authorities. With an anticipated funding amount of $5.6 million for the first year, the application deadline is set for February 21, 2025, and interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    Ending HIV as a public health threat by sustaining and accelerating a comprehensive HIV and TB response in India under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at enhancing the response to HIV and tuberculosis (TB) in India under the President's Emergency Plan for AIDS Relief (PEPFAR). This initiative seeks to support the National AIDS Control Program (NACP) by accelerating HIV epidemic control through comprehensive strategies focused on prevention, case-finding, and treatment in priority regions such as Andhra Pradesh. The program is critical for improving health outcomes and reducing disparities among key populations, with an estimated funding amount of $4 million for the first year and the expectation of awarding 1-2 cooperative agreements. Interested applicants, including government entities, educational institutions, and non-profit organizations, must submit their applications electronically by February 24, 2025, and can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.
    Strengthening comprehensive HIV and TB services and health systems in high-burden areas of Namibia under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a Notice of Funding Opportunity (NOFO) aimed at strengthening comprehensive HIV and tuberculosis (TB) services in high-burden areas of Namibia under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative seeks to enhance facility- and community-based service delivery for HIV and TB, support the Ministry of Health and Social Services (MOHSS) in program oversight, and improve health systems through data-driven approaches and resource mobilization. This funding opportunity is crucial for addressing the high incidence of HIV and TB in Namibia, with an estimated total funding of $15 million available for the first year, potentially awarding 1-3 projects over a five-year period. Applications are due by February 19, 2025, and interested parties can contact Emily Dale at pepfarfoas@cdc.gov for further information.
    Strengthening civil society organizations' capacity and coordination to accelerate HIV epidemic control in Uganda by implementing comprehensive HIV/AIDS prevention and treatment for key and priority populations under PEPFAR
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity aimed at strengthening the capacity and coordination of civil society organizations (CSOs) in Uganda to accelerate HIV epidemic control through comprehensive prevention and treatment services under the PEPFAR initiative. The program specifically targets key populations at high risk of HIV, including female sex workers, men who have sex with men, people who inject drugs, and adolescents, while addressing legal and structural barriers that limit access to healthcare services. With an estimated total funding of $10 million for the first year, the CDC anticipates awarding 1-2 cooperative agreements, with applications due by February 18, 2025, and awards expected to be available starting September 30, 2025. Interested applicants can reach out to Emily Dale at pepfarfoas@cdc.gov for further information.